866-997-4948(US-Canada Toll Free)

DiaGenic ASA (DIAG) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Apr 2012

Category :

Surgical Equipment

No. of Pages : 37 Pages


DiaGenic ASA (DiaGenic) is a life sciences company. It carries out the research, development and sale of modern and user friendly diagnostic tests, which help in early diagnosis of fatal diseases. It is focusing on two different segments in the market, namely, MDx molecular diagnostics and Rx biomarkers for the pharmaceutical industry. The key products of the company include ADtect for early detection of Alzheimer\'s disease and BCtect for early detection of breast cancer. The company makes use of its patented method, which uses the identification of disease-specific gene signatures from easily available sample material such as blood.

This report is a source for data, analysis and actionable intelligence on the DiaGenic ASA portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
DiaGenic ASA - Business Description 6
Key Facts 7
DiaGenic ASA - Major Products and Services 8
DiaGenic ASA Pipeline Products by Equipment Type 9
DiaGenic ASA Pipeline Products by Development Stage 11
DiaGenic ASA Pipeline Products by Therapy Area 13
DiaGenic ASA Pipeline Products by Trial Phase 15
DiaGenic ASA Pipeline Products by Milestone Summary 16
ADtect 18
ADtect Product Status 18
ADtect Product Description 18
ADtect Product Milestone 18
ADtect Product Patent Details 19
ADtect PLUS 24
ADtect PLUS Product Status 24
ADtect PLUS Product Description 24
ADtect PLUS Product Patent Details 24
ADtect ULTRA 25
ADtect ULTRA Product Status 25
ADtect ULTRA Product Description 25
ADtect ULTRA Product Patent Details 25
BCtect 26
BCtect Product Status 26
BCtect Product Description 26
BCtect Product Milestone 26
MCItect 27
MCItect Product Status 27
MCItect Product Description 27
MCItect PLUS 28
MCItect PLUS Product Status 28
MCItect PLUS Product Description 28
MCItect PLUS Product Patent Details 28
MCItect ULTRA 29
MCItect ULTRA Product Status 29
MCItect ULTRA Product Description 29
MCItect ULTRA Product Patent Details 29
PDtect 30
PDtect Product Status 30
PDtect Product Description 30
DiaGenic ASA - Key Competitors 31
DiaGenic ASA - Key Employees 32
DiaGenic ASA - Key Employee Biographies 33
DiaGenic ASA - Locations And Subsidiaries 34
Head Office 34
Recent Developments 35
DiaGenic ASA, Recent Developments 35
Apr 17, 2012: DiaGenic Announces Resignation Of Erik Christensen As CEO 35
Oct 27, 2011: DiaGenic Reports Q3 2011 Results 35
Oct 14, 2011: Findings From DiaGenic, Pfizer R&D Collaboration Show Promising Early Results For Blood-Based Test For Early Alzheimer Disease 35
Oct 06, 2011: DiaGenic Secures Notice Of Allowance Of US Family 3 Breast Cancer Patent 36
Aug 19, 2011: DiaGenic Reports Total Operating Revenues Of NOK1.2m In Q2 2011 36
Jun 07, 2011: DiaGenic Appoints Magnus Sjogren As New CMO 36
May 11, 2011: DiaGenic Reports Total Operating Revenues Of NOK1.6m In Q1 2011 36

Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Table


DiaGenic ASA, Key Facts 1
DiaGenic ASA Key Pipeline Products by Equipment Type 1
DiaGenic ASA Key Pipeline Products by Therapy Area 1
DiaGenic ASA Key Pipeline Products by Development Stage 1
DiaGenic ASA Key Pipeline Products by Trial Phase 1
DiaGenic ASA, Key Facts 7
DiaGenic ASA, Major Products and Services 8
DiaGenic ASA Number of Pipeline Products by Equipment Type 9
DiaGenic ASA Pipeline Products by Equipment Type 10
DiaGenic ASA Number of Pipeline Products by Development Stage 11
DiaGenic ASA Pipeline Products by Development Stage 12
DiaGenic ASA Number of Pipeline Products by Therapy Area 13
DiaGenic ASA Pipeline Products by Therapy Area 14
DiaGenic ASA Number of Pipeline Products by Trial Phase 15
DiaGenic ASA Pipeline Products by Trial Phase 15
DiaGenic ASA Number of Pipeline Products By Milestone Summary 16
DiaGenic ASA Pipeline Products by Milestone Summary 17
ADtect - Product Status 18
ADtect - Product Description 18
ADtect - Product Milestone 18
ADtect - Patent Details 19
ADtect PLUS - Product Status 24
ADtect PLUS - Product Description 24
ADtect PLUS - Patent Details 24
ADtect ULTRA - Product Status 25
ADtect ULTRA - Product Description 25
ADtect ULTRA - Patent Details 25
BCtect - Product Status 26
BCtect - Product Description 26
BCtect - Product Milestone 26
MCItect - Product Status 27
MCItect - Product Description 27
MCItect PLUS - Product Status 28
MCItect PLUS - Product Description 28
MCItect PLUS - Patent Details 28
MCItect ULTRA - Product Status 29
MCItect ULTRA - Product Description 29
MCItect ULTRA - Patent Details 29
PDtect - Product Status 30
PDtect - Product Description 30
DiaGenic ASA, Key Employees 32
DiaGenic ASA, Key Employee Biographies 33

List of Chart


DiaGenic ASA Pipeline Products by Equipment Type 9
DiaGenic ASA Pipeline Products by Development Stage 11
DiaGenic ASA Pipeline Products by Therapy Area 13
DiaGenic ASA Pipeline Products by Trial Phase 15
DiaGenic ASA Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *